Thanking all the delegates, FCQ Elites, Oral session & IDC presenters, Guest speakers, Moderators, Co-organizers: NCGM, SIT, GSZ, TPRM, Volunteers & Service providers for your contribution to NCRM NICHE 2017 in Tokyo, Japan. See you all in NCRM NICE 2018 on the 21 & 22 October 2018- The Organizing committee with NCRM, EELS, GNC & Genotec


Prof. Jurgen Hescheler
Head, Neurophysiology, University of Cologne, Germany

Prof. Dr. Jürgen Hescheler is a German physician and stem cell researcher. He is director to the Institute for Neurophysiology and a university professor at the University of Cologne. Prof. Hescheler is one of the most eminent embryonic stem cell researchers worldwide. Prof. Hescheler has been working with embryonic stem cells since the late 80's. He became the first researcher to accomplish electrophysiological characterisation of stem cells and was also among the first scientists in Germany obtaining permission to do research on human embryonic stem cells.

Prof. Takahiro Ochiya
Head, Molecular & Cellular Medicine, National Cancer Centre, Tokyo, Japan

Dr. Takahiro Ochiya's lab focuses the development of novel animal models, methods, and strategies to study cancer development and metastasis. Especially, current focuses are siRNA- and microRNA-based therapy and exosome-mediated tumor metastasis. Dr. Ochiya has authored more than 260 peer-reviewed publications including 40 review articles, holds 24 Japan and 12 U.S. & Europe patents, and contributed to several books on stem cells, Extracellular vesicles, and RNAi medicine. Dr. Ochiya is a chief scientist of current Japan project of the Development of Diagnostic Technology for Detection of miRNA in Body Fluids (supported by NEDO/AMED).

Dr. Hiroshi Yoshioka
Mebiol Inc., Japan

Dr. Hiroshi Yoshioka is a polymer scientist and is the Chief Technical officer of M/S Mebiol Inc. He also chairs a visiting associate professorship in the Waseda University, Tokyo. Dr Yoshioka has more than 200 patents and several publications. Mebiol Inc. also specializes in advanced polymer membrane based technologies for cell culture and cell based therapeutics.

Dr. Suryaprakash Vaddi
Virinchi Hospitals, Hyderabad, India

Dr. Suryaprakash Vaddi is a Senior Consultant Urologist, Andrologist and Transplant Surgeon in the Department of Urology at Virinchi Hospitals. He has overall 15 years' experience in his field. Prior to joining Virinchi Hospitals, he worked as Assistant Professor, Department of Urology, NIMS, Hyderabad and Head, Department of Urology and Renal Transplantation, Narayana Medical College & Hospital, Nellore. He underwent advanced laparoscopic surgery and robotic surgery training at IRCAD, Strasbourg, France. His areas of interest include laparoscopic urology, advanced endourology, uro-oncology and reconstructive urology.

Prof. Gary Levy
Dept. of Medicine, Immunology and Surgery, Univ. of Toronto, Canada

Dr. Gary Levy graduated from medical school at the University of Toronto in 1973. Following postdoctoral training in immunology at the Scripps Clinic and Research Foundation he returned to the University of Toronto. He was the Director of the Multi Organ Transplant Program at the University Health Network from 1990 to 2013 and the Director of the University of Toronto Transplant Institute. He is currently a Professor in the Departments of Medicine and Surgery at the University of Toronto. In addition to his clinical and administrative duties, he has achieved international recognition for his research in studies of the immunopathogenesis of viral hepatitis, transplant rejection and tolerance. He has published over 350 peer reviewed articles and has trained over 60 Masters and PhD students.